Home » Hoyer on MFG: At stake is rising premiums that enable pharmaceutical income…

Hoyer on MFG: At stake is rising premiums that enable pharmaceutical income…

by admin
Hoyer on MFG: At stake is rising premiums that enable pharmaceutical income…

17.05.2024 – 12:55

AOK Federal Association

Berlin (ots)

During the primary studying of the Medical Research Act (MFG) within the Federal Council, Jens Martin Hoyer, vice-chairman of the AOK, helps the necessity of the states to take away hidden costs from the draft legislation and says:

“We welcome the choice of the National Assembly right now to take away confidential pricing of latest medicine from the Medical Research Act. The introduction of confidential reimbursement charges would result in a fantastic lack of transparency and a excessive stage of administrative and monetary effort, which is incompatible with accountable financial issues. In normal, nobody appears to suppose that confidential pricing is a good suggestion: Any the medical sector, or the non-public medical health insurance corporations and even components of the pharmaceutical business which can be clearly in opposition to them from the top?

At least not the union insurance coverage neighborhood. In 2024, the quantity of projected prices of the official medical health insurance system is already at a document stage of 314 billion euros, one driver being the price of drugs, which at all times makes the second largest merchandise. Private pricing results in further monetary burdens that run into the billions and in the end to greater premiums with out enhancing care.

It appears unlikely that a few of the pharmaceutical corporations from the remaining non-public pricing camp declare that they solely need non-public reimbursement charges in uncommon circumstances. Because if it was really about peanuts, the entire train, together with the controversy, can be utterly unbalanced.

See also  Naples, anti-Sma drug administered to a 21-day-old girl

The federal authorities desires to make use of MFG to extend Germany’s attractiveness as a analysis location. However, donors shouldn’t be used to assist this native coverage, particularly if this doesn’t result in any enchancment of their care.”

Contact individual on the press workplace:

Dr. Kai Behrens
Phone: 030 / 34646-2309
Mobile: 01520 / 1563042
Email: [email protected]

Original content material from: AOK Federal Association, broadcast by information aktuell

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy